Comments on: Transparency on Pharma Opposition to Transparency http://blog.hcfama.org/2009/01/11/transparency-on-pharma-opposition-to-transparency/ The Ultimate Massachusetts Health Care Insider Information Mon, 13 Feb 2012 20:02:38 +0000 hourly 1 http://wordpress.com/ By: Ken Farbstein http://blog.hcfama.org/2009/01/11/transparency-on-pharma-opposition-to-transparency/#comment-2154 Tue, 13 Jan 2009 10:13:10 +0000 http://blog.hcfama.org/?p=2205#comment-2154 There’s a loophole here big enough to drive a drug salesman’s yacht through: disclosure of research funding, as well as gifts.

The victims affected by this issue may still seem anonymous. Here’s the story of John Eric Kauffman, a victim of a fatal side-effect of the aggressively-marketed drug Zyprexa.

]]>